Chadwick Jeremy G sold 3,730 shares of Kymera Therapeutics, Inc. at $78.36 for −$292k on May 26, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Operating Officer
Chief Operating Officer
Filed May 27, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$292,271.24Shares × reported price
Shares traded
3,730Common Stock
Price per share
$78.36Reported price. Read footnotes for ranges.
% of reported position traded
6.09%This security and ownership context
Holdings after
57,472Direct
Trade date
May 26, 2026Sell
Filed
May 27, 2026, 5:50 PM ET1-day reporting delay
Accession
0001193125-26-242266Code S · Transaction 89270
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 61,202 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 26, 2026Sell324$79.17−$25,651.08Trade 89271
May 26, 2026Sell3,800$79.39−$301,690.74Trade 89272
May 26, 2026Sell4,500$80.02−$360,110.70Trade 89273
May 26, 2026Sell551$80.71−$44,470.22Trade 89274
May 27, 2026Sell3,679$81.50−$299,849.54Trade 89275
May 27, 2026Sell600$82.08−$49,246.02Trade 89276
7 transaction rows in this filing. Joint filers share the same rows.

KYMR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
KYMR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +3.9%1w ago −4.4%1d ago −3.4%
Returns since7d −10%30d +32%90d +52%180d1y

Footnotes in full

F1: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the reporting person. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.99 to $78.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.66 to $79.655, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.66 to $80.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.70 to $80.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.985 to $81.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.99 to $82.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.